These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 20630410)

  • 1. Outcomes associated with anemia in patients with heart failure.
    Salisbury AC; Kosiborod M
    Heart Fail Clin; 2010 Jul; 6(3):359-72. PubMed ID: 20630410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The economic burden of anemia in heart failure.
    Spence RK
    Heart Fail Clin; 2010 Jul; 6(3):373-83. PubMed ID: 20630411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mediators of anemia in chronic heart failure.
    Le Jemtel TH; Arain S
    Heart Fail Clin; 2010 Jul; 6(3):289-93. PubMed ID: 20630403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiorenal anemia syndrome: do erythropoietin and iron therapy have a place in the treatment of heart failure?
    Pagourelias ED; Koumaras C; Kakafika AI; Tziomalos K; Zorou PG; Athyros VG; Karagiannis A
    Angiology; 2009; 60(1):74-81. PubMed ID: 18413330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Future directions in management of anemia in heart failure.
    Agarwal AK; Katz SD
    Heart Fail Clin; 2010 Jul; 6(3):385-95. PubMed ID: 20630412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of anemia in heart failure.
    Stamos TD; Silver MA
    Curr Opin Cardiol; 2010 Mar; 25(2):148-54. PubMed ID: 19996965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erythropoietin in heart failure.
    Silverberg DS; Wexler D; Blum M; Iaina A; Sheps D; Keren G; Schwartz D
    Semin Nephrol; 2005 Nov; 25(6):397-403. PubMed ID: 16298262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment with iron of patients with heart failure with and without anemia.
    Jelani QU; Attanasio P; Katz SD; Anker SD
    Heart Fail Clin; 2010 Jul; 6(3):305-12. PubMed ID: 20630405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anemia in chronic heart failure.
    Drakos SG; Anastasiou-Nana MI; Malliaras KG; Nanas JN
    Congest Heart Fail; 2009; 15(2):87-92. PubMed ID: 19379455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erythropoietin improves anemia exercise tolerance and renal function and reduces B-type natriuretic peptide and hospitalization in patients with heart failure and anemia.
    Palazzuoli A; Silverberg D; Iovine F; Capobianco S; Giannotti G; Calabrò A; Campagna SM; Nuti R
    Am Heart J; 2006 Dec; 152(6):1096.e9-15. PubMed ID: 17161060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency.
    Toblli JE; Lombraña A; Duarte P; Di Gennaro F
    J Am Coll Cardiol; 2007 Oct; 50(17):1657-65. PubMed ID: 17950147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapy insight: congestive heart failure, chronic kidney disease and anemia, the cardio-renal-anemia syndrome.
    Iaina A; Silverberg DS; Wexler D
    Nat Clin Pract Cardiovasc Med; 2005 Feb; 2(2):95-100. PubMed ID: 16265380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous iron alone is equally effective with the combination of iron and erythropoietin for the treatment of iron-deficiency anemia in advanced heart failure.
    Terrovitis JV; Kaldara E; Ntalianis A; Sventzouri S; Kapelios C; Barbarousi D; Matsouka C; Nanas JN
    J Am Coll Cardiol; 2012 Nov; 60(21):2255-6. PubMed ID: 23103041
    [No Abstract]   [Full Text] [Related]  

  • 14. Improvement of anemia with erythropoietin and intravenous iron reduces sleep-related breathing disorders and improves daytime sleepiness in anemic patients with congestive heart failure.
    Zilberman M; Silverberg DS; Bits I; Steinbruch S; Wexler D; Sheps D; Schwartz D; Oksenberg A
    Am Heart J; 2007 Nov; 154(5):870-6. PubMed ID: 17967592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anemia in chronic heart failure: prevalence, etiology, clinical correlates, and treatment options.
    Tang YD; Katz SD
    Circulation; 2006 May; 113(20):2454-61. PubMed ID: 16717164
    [No Abstract]   [Full Text] [Related]  

  • 16. Prevalence, prognostic importance and therapeutic implications of anemia in heart failure.
    Mishra TK; Mishra SK; Mohanty NK; Rath PK
    Indian Heart J; 2005; 57(6):670-4. PubMed ID: 16521636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The interaction among sex, hemoglobin and outcomes in a specialty heart failure clinic.
    Ezekowitz JA; McAlister FA; Armstrong PW
    Can J Cardiol; 2005 Feb; 21(2):165-71. PubMed ID: 15729416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anemia and outcomes in patients with heart failure: a study from the National Heart Care Project.
    Kosiborod M; Curtis JP; Wang Y; Smith GL; Masoudi FA; Foody JM; Havranek EP; Krumholz HM
    Arch Intern Med; 2005 Oct; 165(19):2237-44. PubMed ID: 16246989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rationale and design of the IRON-HF study: a randomized trial to assess the effects of iron supplementation in heart failure patients with anemia.
    Beck-da-Silva L; Rohde LE; Pereira-Barretto AC; de Albuquerque D; Bocchi E; Vilas-Boas F; Moura LZ; Montera MW; Rassi S; Clausell N
    J Card Fail; 2007 Feb; 13(1):14-7. PubMed ID: 17338998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The hidden woes of anemia and sleep-disordered breathing in heart failure: killing two birds with one stone.
    Young JB
    Am Heart J; 2007 Nov; 154(5):805-7. PubMed ID: 17967582
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.